BDNF and Behcet disease: The replication of abnormalities in neurotrophins, inflammatory interleukins mediators, monoamine metabolites and oxidative stress species in independent studies leads to the postulation that this association could be regarded as a feasible biomarker and an indicator of BD progression [72].